A new Xarelto lawsuit was filed against Janssen Research & Development LLC, a subsidiary of Johnson & Johnson, and Bayer Pharmaceuticals.

The Xarelto lawsuit is a part of the multidistrict litigation involving the blood-thinning medication that is before the U.S. District Judge Fallon.

According to the Xarelto lawsuit, Plaintiff Gerald F., a resident of Travis County Texas began taking Xarelto in November of 2013 as prescribed by his physician. He continued to take the anticoagulant drug until July of 2014.

Gerald alleges that as a direct result of taking Xarelto he suffered melena, or bloody stool, in November of 2013 and a gastrointestinal bleed in February of 2014. Due to the gastrointestinal bleeding, Gerald was hospitalized for 3 days and received transfusions of four units of red blood cells.

The Xarelto injury lawsuit alleges that the defendants failed to warn the medical community and the general public about dangerous side effects associated with taking Xarelto. Additionally, Gerald alleges that as part of its marketing scheme, Xarelto marketers participated in direct to consumer advertising campaigns that were designed to influence patients to ask for Xarelto above other blood thinning medications.

According to Gerald’s complaint, Xarelto advertised itself as a superior alternative to the more traditional blood thinner warfarin. It is alleged that Xarelto was advertised to not require any blood monitoring, but the lawsuit suggests that studies show without appropriate blood monitoring, dose adjustment, and twice a day dosing patients are at risk of major life-threatening bleeding events.

About Xarelto

Xarelto is a popular blood thinning medication that was introduced to the US market in July of 2011. It was approved to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, to treat deep vein thrombosis and pulmonary embolism, and to prevent these conditions in patients undergoing hip or knee replacement surgery.

Xarelto along with other oral anticoagulants in its class were introduced as a replacement for warfarin which requires patients follow dietary restrictions and undergo constant blood monitoring.

According to the FDA adverse event reports, Xarelto patients reported 680 adverse events reports submitted with its competitor Pradaxa following with 528. Prior to Xarelto’s release, Pradaxa had been ranked number one in the quantity of FDA-reported adverse events.

Xarelto Lawsuits

Product liability attorneys are currently looking for potential plaintiffs to bring Xarelto lawsuits against the pharmaceutical manufacturers. These lawsuits will likely allege that the companies violated consumer protection laws. Successful plaintiffs will likely receive monetary compensation for their past medication bills and the pain and suffering they experienced due to taking the medication.

The Xarelto Lawsuit is Case No. 2:15-cv-05978-EEF-MBN in the US District Court in the Eastern District of Louisiana.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Xarelto attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Xarelto class action lawsuit is best for you. [In general, Xarelto lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.

Learn More

Get Help – It’s Free

Join a Free Xarelto Class Action Lawsuit Investigation

If you or a loved one took Xarelto (rivaroxaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, deep vein thrombosis or pulmonary embolism, you may have a legal claim. See if you qualify by filling out the short form below.

An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.

First Name*
Last Name*
Street Address*
Apt. #
City*
State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
Zip Code*
Phone*
Email*
Which blood thinner did you or a loved one take at the time of the injury or injuries?*
- Pradaxa
- Xarelto
- Unknown
- Other
Please check the injuries suffered:*
- Death
- Gastrointestinal Bleeding
- Other Internal Bleeding
- Cerebral Hemorrhaging
- Ischemic Stroke
- Unsure
- None
¿Necesita un orador español?
- Yes
- No
Please enter any additional details you would like the staff reviewing your submission to know.*
I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
- Yes

if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 35) {gformInitChosenFields(‘#input_35_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_35_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_35_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [35, 1]) } );

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

Email*
State*
selectAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific

jQuery(document).ready(function($){gformInitSpinner( 5, ‘http://11284-presscdn-0-40.pagely.netdna-cdn.com/wp-content/plugins/gravityforms/images/spinner.gif’ );jQuery(‘#gform_ajax_frame_5’).load( function(){var contents = jQuery(this).contents().find(‘*’).html();var is_postback = contents.indexOf(‘GF_AJAX_POSTBACK’) >= 0;if(!is_postback){return;}var form_content = jQuery(this).contents().find(‘#gform_wrapper_5’);var is_confirmation = jQuery(this).contents().find(‘#gform_confirmation_wrapper_5’).length > 0;var is_redirect = contents.indexOf(‘gformRedirect(){‘) >= 0;var is_form = form_content.length > 0 && ! is_redirect && ! is_confirmation;if(is_form){jQuery(‘#gform_wrapper_5’).html(form_content.html());setTimeout( function() { /* delay the scroll by 50 milliseconds to fix a bug in chrome */ jQuery(document).scrollTop(jQuery(‘#gform_wrapper_5’).offset().top); }, 50 );if(window[‘gformInitDatepicker’]) {gformInitDatepicker();}if(window[‘gformInitPriceFields’]) {gformInitPriceFields();}var current_page = jQuery(‘#gform_source_page_number_5’).val();gformInitSpinner( 5, ‘http://11284-presscdn-0-40.pagely.netdna-cdn.com/wp-content/plugins/gravityforms/images/spinner.gif’ );jQuery(document).trigger(‘gform_page_loaded’, [5, current_page]);window[‘gf_submitting_5’] = false;}else if(!is_redirect){var confirmation_content = jQuery(this).contents().find(‘#gforms_confirmation_message_5’).html();if(!confirmation_content){confirmation_content = contents;}setTimeout(function(){jQuery(‘#gform_wrapper_5’).replaceWith(” + confirmation_content + ”);jQuery(document).scrollTop(jQuery(‘#gforms_confirmation_message_5’).offset().top);jQuery(document).trigger(‘gform_confirmation_loaded’, [5]);window[‘gf_submitting_5’] = false;}, 50);}else{jQuery(‘#gform_5’).append(contents);if(window[‘gformRedirect’]) {gformRedirect();}}jQuery(document).trigger(‘gform_post_render’, [5, current_page]);} );} ); if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 5) {gformInitChosenFields(‘#input_5_2′,’No results matched’);} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_5_2′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [5, 1]) } );

Top Class Actions is a Proud Member of the American Bar Association

american-bar-association